Loading clinical trials...

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia | Clinical Trials | Clareo Health

COMPLETEDPHASE2/PHASE3

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia

The Effect of Colistin Inhalation on the Clinical Outcome of Patients With Ventilator Associated Pneumonia

NCT03622450•Nourhan Hassan Osama Thuraya Mohamed

Summary

The study has been conducted to measure the clinical outcome of early intervention with colistin inhalation in patients with ventilator associated pneumonia suspected to have multidrug resistant gram -ve bacteria

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age 18 years
•Patients presenting with signs of infection 48 hours of intubation

Exclusion Criteria

•Patients with documented bronchiectasis
•Cystic fibrosis Known allergy to polymyxin. Patients presenting with chest infection or signs of infection before intubation.
•Patients with creatinine clearance less than 30ml/min.

Key Dates

Start Date

January 2, 2016

Primary Completion Date

January 6, 2018

Completion Date

January 10, 2018

Last Updated

August 9, 2018

Enrollment

ACTUAL participants

Conditions

Ventilator Associated Pneumonia

Interventions

Colistin

DRUG

Carbapenem + Aminoglycoside/ Quinolone

DRUG

Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

NCT06554327

Ventilator Associated Pneumonia

View study

RECRUITING

LUNG INFECTION in ICU (LUNG-I3)

NCT06073834

VAP - Ventilator Associated Pneumonia

View study

COMPLETEDPHASE4

Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

NCT07369336

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia

Inclusion Criteria

Exclusion Criteria

Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

LUNG INFECTION in ICU (LUNG-I3)

Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units

7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia

Heparin Binding Protein Versus Platelet Count and Mean Platelet Volume Kinetics in the Diagnosis and Prognosis of VAP